Exagen Inc. Common Stock (XGN) is a publicly traded Healthcare sector company. As of July 21, 2026, XGN trades at $4.75 with a market cap of $106.06M and a P/E ratio of -5.38. XGN moved +1.50% today. Year to date, XGN is -22.13%; over the trailing twelve months it is -33.14%. Its 52-week range spans $2.59 to $12.23. Analyst consensus is strong buy with an average price target of $8.00. Rallies surfaces XGN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
4 analysts cover XGN: 0 strong buy, 4 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $8.00.
| Metric | Value |
|---|---|
| Price | $4.75 |
| Market Cap | $106.06M |
| P/E Ratio | -5.38 |
| EPS | $-0.89 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.23 |
| 52-Week Low | $2.59 |
| Volume | 189.06K |
| Avg Volume | 0 |
| Revenue (TTM) | $68.38M |
| Net Income | $-20.17M |
| Gross Margin | 58.32% |
4 analysts cover XGN: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.00.